Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Bolt Biotherapeutics Inc BOLT

Healthcare Biotechnology
Bolt Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer. The Company's pipeline candidates are built on its expertise in myeloid biology and cancer drug development. Its pipeline includes trastuzumab imbotolimod (formerly BDC-1001), a human epidermal growth factor receptor 2 - targeting Boltbody Immune-Stimulating... see more

Bullboard (NDAQ:BOLT)

View:
Post by TitanEquity52on Nov 27, 2024 4:00pm

BOLT's Market Cap at $7.69M—Undervalued Play?

With a market cap of $7.69 million, Bolt Metals is flying under the radar. For those seeking exposure to junior miners, this could be a speculative opportunity.
13
Post by TradeVanguard27on Nov 27, 2024 3:54pm

BOLT Completes NI 43-101 Report for Switchback Property—Reso

Bolt Metals has wrapped up its NI 43-101 technical report for the Switchback Copper-Silver Property. This milestone could pave the way for resource estimates and future development. Investors, watch ...more  
21
Post by IronBull27on Nov 25, 2024 2:31pm

Montana Mines Lead the Way for $BOLT.CN

$BOLT.CN's strategic push into Montana mining highlights its long-term vision. Resource potential in this region supports the booming industrial metals market, with added green energy tailwinds ...more  
20
Post by PivotMaster77on Nov 25, 2024 11:55am

Momentum Plays: $SNOW and $BOLT.CN

$SNOW ripped higher from the open, now consolidating into a bullish flag—key resistance at $180 could open the door to new highs. $BOLT.CN remains steady above its 200-day MA, with demand for ...more  
22
Post by MikeTesteron Aug 03, 2024 4:17pm

Bolt Biotherapeutics, Inc. (NASDAQ:BOLT): Pivoting to a Focu

https://beyondspx.com/2024/08/02/bolt-biotherapeutics-inc-nasdaqbolt-pivoting-to-a-focused-pipeline-and-streamlined-operations-to-maximize-shareholder-value/
48
Post by whytestockson Jun 12, 2023 7:15pm

Diagnostear, a subsidiary of BioLight Life Sciences Ltd, sig

News; $BOLT Diagnostear, a subsidiary of BioLight Life Sciences Ltd, signed a binding Letter of Intent for merger, capital raise and listing on the Canadian Securities ExchangeDiagnostear, a ...more  
93
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities